Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
FDA Approvals
FDA Approvals
,
In the News
,
Select Drug Profiles
FDA Approves New Oral Therapy to Treat ALK-Positive Lung Cancer
Read More
FDA Approvals
,
In the News
,
Select Drug Profiles
FDA Approves Empliciti, a New Immune-Stimulating Therapy to Treat Multiple Myeloma
Read More
FDA Approvals
,
In the News
,
Select Drug Profiles
FDA Approves Ninlaro, New Oral Medication to Treat Multiple Myeloma
Read More
FDA Approvals
,
In the News
,
Select Drug Profiles
FDA Approves Darzalex for Patients with Previously Treated Multiple Myeloma
Read More
FDA Approvals
,
In the News
,
Select Drug Profiles
FDA Approves Praxbind, the First Reversal Agent for the Anticoagulant Pradaxa
Read More
FDA Approvals
FDA Update
Read More
FDA Approvals
Recent FDA Approvals
Read More
FDA Approvals
,
Payers' Guide
The Sixth Annual Payers’ Guide to New FDA Approvals
Read More
FDA Approvals
Idelalisib Approved for 3 Types of Hematologic Cancers
Read More
FDA Approvals
Belinostat Approved for Peripheral T-Cell Lymphoma
Read More
24
25
26
27
28
29
30
Page 27 of 31
Results 261 - 270 of 305